Arbutus Biopharma Corporation
ABUS
$4.58
$0.173.86%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 4.11% | -2.38% | -4.47% | -12.97% | -8.09% |
| Total Receivables | 10,229.31% | 44.98% | 7.11% | -18.60% | -48.98% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 7.59% | -51.16% | -35.10% | 43.66% | 37.05% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 193.27% | -3.06% | -5.51% | -11.72% | -8.25% |
|
|
|||||
| Total Current Assets | 193.27% | -3.06% | -5.51% | -11.72% | -8.25% |
| Net Property, Plant & Equipment | -31.25% | -76.64% | -7.43% | -11.90% | -96.14% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 0.77% | -0.76% | -- | -- | 0.00% |
| Total Assets | 192.93% | -3.16% | -5.38% | -11.75% | -11.16% |
|
|
|||||
| Total Accounts Payable | 24.64% | 16.02% | -23.47% | -41.03% | -3.28% |
| Total Accrued Expenses | -24.11% | 26.64% | 19.02% | -38.04% | -25.61% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 15.36% | 3.01% | 3.31% | -8.70% | 16.56% |
| Total Finance Division Other Current Liabilities | -61.72% | -16.12% | -0.65% | -93.96% | 68.06% |
| Total Other Current Liabilities | -61.72% | -16.12% | -0.65% | -93.96% | 68.06% |
| Total Current Liabilities | -15.00% | 15.86% | 3.23% | -74.15% | 24.41% |
|
|
|||||
| Total Current Liabilities | -15.00% | 15.86% | 3.23% | -74.15% | 24.41% |
| Long-Term Debt | -4.76% | -6.57% | -5.78% | -11.32% | -8.70% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -49.10% | -32.00% | -8.15% | -22.33% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 2.49% | -24.04% | 2.49% | -19.44% | 2.28% |
| Total Liabilities | -5.85% | -11.17% | 0.10% | -46.40% | 10.23% |
|
|
|||||
| Common Stock & APIC | 0.93% | 0.19% | 0.14% | 0.09% | 0.43% |
| Retained Earnings | 12.30% | -0.27% | -0.57% | 0.18% | -1.82% |
| Treasury Stock & Other | -0.20% | 0.06% | 0.12% | -0.04% | -0.06% |
| Total Common Equity | 239.76% | -1.06% | -6.72% | 4.82% | -18.70% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 239.76% | -1.06% | -6.72% | 4.82% | -18.70% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 239.76% | -1.06% | -6.72% | 4.82% | -18.70% |
|
|
|||||